Overview of the 2019 Allergic Rhinitis and its Impact on Asthma (ARIA) Next-Generation Update

Authors

  • Susan Waserman, MSc, MD, FRCPC
  • Anita Shah, HBSc

DOI:

https://doi.org/10.58931/cait.2021.1s026

Abstract

In 2019 and 2020, two guidelines on the pharmacotherapeutic management of allergic rhinitis (AR) were updated using a Grading of Recommendations, Assessment, Development and Evaluation (GRADE)-based approach or a mixed GRADE and consensus-based approach. This article will provide a synopsis of the 2019 ARIA (Allergic Rhinitis and Its Impact on Asthma) next-generation update, including comparisons to relevant recommendations made by the 2016 ARIA revision and 2020 AAAAI (American Academy of Allergy, Asthma, and Immunology) Rhinitis Practice Parameter.

Author Biographies

Susan Waserman, MSc, MD, FRCPC

Dr. Susan Waserman is a Professor of Medicine, Director of the Division of Clinical Immunology and Allergy at McMaster University and the Adverse Reactions Clinic at the Firestone Institute of Respiratory Health, St. Joseph’s Healthcare. Dr. Waserman is extensively involved in medical education in both academic and community settings, in addition to an active hospital-based clinical practice in adult and pediatric allergy and clinical immunology. Her clinical activities include practice guidelines in food allergy, allergic rhinitis, hereditary angioedema and urticaria. Her research interests are focused on mechanisms of peanut allergy and its treatment. She is President of the Canadian Allergy, Asthma and Immunology Foundation and past President of the Canadian and Ontario Societies of Allergy and Clinical Immunology.

Anita Shah, HBSc

Anita Shah is a research assistant within the division of Clinical Immunology and Allergy at McMaster University. She is the co-founder of the McMaster Food Allergy Club and has single-handedly supported many children as a mentor by helping them build the confidence they need to advocate for themselves and to better manage their food allergy in their everyday lives.

References

Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, et al. ARIA Guideline 2019: Treatment of allergic Rhinitis in the German Healthcare System. Allergol Select. 2019 Dec 30;3(1):22-50. doi:10.5414/ALX02120E

Dykewicz MS, Wallac DV, Amrol DJ, Baroody FM, Bernstein JA, Craig TJ, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol. 2020 Oct;146(4):721-767. doi:10.1016/j.jaci.2020.07.007

Brożek, JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Antcevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017 Oct;140(4):950-958. doi:10.1016/j.jaci.2017.03.050

Overview of the 2019 Allergic Rhinitis and its Impact on Asthma (ARIA) Next-Generation Update

Downloads

Published

2021-02-01

How to Cite

1.
Waserman S, Shah A. Overview of the 2019 Allergic Rhinitis and its Impact on Asthma (ARIA) Next-Generation Update. Can Allergy Immunol Today [Internet]. 2021 Feb. 1 [cited 2024 Nov. 21];1(s02):3–7. Available from: https://canadianallergyandimmunologytoday.com/article/view/1-s02-waserman_et_al

Issue

Special Supplement, February 2021

Section

Articles

Most read articles by the same author(s)